We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$38B
AUM Growth
-$403M
Cap. Flow
-$1.41B
Cap. Flow %
-3.71%
Top 10 Hldgs %
12.73%
Holding
2,268
New
326
Increased
746
Reduced
765
Closed
304

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$261M
2
UBER icon
Uber
UBER
+$173M
3
BAH icon
Booz Allen Hamilton
BAH
+$168M
4
V icon
Visa
V
+$116M
5
CAVA icon
CAVA Group
CAVA
+$106M

Sector Composition

Rank Sector Weight
1 Technology 22.31%
2 Consumer Discretionary 12.48%
3 Financials 10.89%
4 Healthcare 8.97%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
1826
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$57K ﹤0.01%
+100
New +$58.6K
MDY icon
1827
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$57K ﹤0.01%
100
-1,086
-92% -$637K
ATYR
1828
aTyr Pharma
ATYR
$46.4M
$55.2K ﹤0.01%
+15,248
New +$46.2K
VTGN icon
1829
VistaGen Therapeutics
VTGN
$9.29M
$54.1K ﹤0.01%
+18,338
New +$51.6K
DOUG icon
1830
Douglas Elliman
DOUG
$155M
$51.6K ﹤0.01%
+30,889
New +$59.4K
SLRN
1831
DELISTED
ACELYRIN
SLRN
$47.7K ﹤0.01%
15,193
+1,578
+12% +$7.64K
WHWK
1832
Whitehawk Therapeutics
WHWK
$183M
$45.7K ﹤0.01%
14,484
-11
-0.1% -$25
GNLX icon
1833
Genelux
GNLX
$130M
$39.3K ﹤0.01%
16,656
-241
-1% -$641
SEER icon
1834
Seer Inc
SEER
$108M
$37.6K ﹤0.01%
16,288
-185,509
-92% -$407K
CKPT
1835
DELISTED
Checkpoint Therapeutics
CKPT
$34.9K ﹤0.01%
+10,919
New +$37K
IMRX icon
1836
Immuneering
IMRX
$279M
$30.6K ﹤0.01%
13,914
+136
+1% +$282
GEVO icon
1837
Gevo
GEVO
$397M
$21.1K ﹤0.01%
+10,116
New +$19.2K
PSNY icon
1838
Polestar Automotive Holding UK
PSNY
$1.98B
$15.2K ﹤0.01%
482
-13,836
-97% -$502K
NKLA
1839
DELISTED
Nikola Corporation Common Stock
NKLA
$12.9K ﹤0.01%
+10,808
New +$30.9K
UWMC.WS
1840
DELISTED
UWM Holdings Warrants
UWMC.WS
$12.7K ﹤0.01%
61,937
SGMO
1841
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$10.4K ﹤0.01%
+10,185
New +$18.6K
COCHW icon
1842
Envoy Medical Warrant
COCHW
$536K
$8.92K ﹤0.01%
183,191
-163,008
-47% -$10.1K
RBOT.WS
1843
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$5.52K ﹤0.01%
225,459
-17,659
-7% -$630
MNYWW
1844
MoneyHero Ltd Warrants
MNYWW
$5.15K ﹤0.01%
93,352
-83,067
-47% -$3.4K
ADNWW
1845
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$1.71K ﹤0.01%
211,157
-16,522
-7% -$165
TOIIW
1846
The Oncology Institute Warrant
TOIIW
$622 ﹤0.01%
88,824
AMBP.WS
1847
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$345 ﹤0.01%
11,501
+28
+0.2% +$1
ACHC icon
1848
Acadia Healthcare
ACHC
$3.17B
-23,801
Closed -$1.51M
ACIU icon
1849
AC Immune
ACIU
$227M
-27,361
Closed -$103K
ACLS icon
1850
Axcelis
ACLS
$4.12B
-101,655
Closed -$10.7M

Similar funds

Man Group's Q4 2024 Portfolio in Review

As of Q4 2024, Man Group held 2,268 positions worth $38B, down 1.1% from $38.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group withdrew a net $1.41B in Q4 2024, closing 304 positions and reducing 765 holdings. Its most notable exit was Stericycle Inc, an estimated $53.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Man Group opened a new position in Bunge Global worth $50.6M.

  • Man Group's largest Q4 2024 buy was Bunge Global: 650,217 shares worth $50.6M.
  • Man Group added most to Booking.com in Q4 2024, an estimated $261M increase.
  • Man Group's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $172M.
  • Man Group fully exited Stericycle Inc in Q4 2024, selling an estimated $53.8M.
  • Man Group's ten largest holdings make up 13% of its $38B portfolio in Q4 2024.
  • Man Group opened 326 new positions and closed 304 in Q4 2024.
  • Man Group's portfolio value fell 1.1% quarter-over-quarter to $38B.

Based on Man Group's 13F filing for Q4 2024, filed 14 Feb 2025.